Related Experiment Video
Updated: May 26, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Immunophenotypic profile of intrahepatic and circulating lymphocytes in chronic hepatitis B patients
Guolei Tan1, Wei Zhao, Xinyu Liu
1Nanjing Second Hospital, Nanjing, China.
Background/Aims:
Persistent hepatitis B virus (HBV) infection is associated with particular deficiencies in the host immune system. To gain insight into the role of lymphocyte subsets involved in viral clearance and hepatic injury.
Methodology:
The immunophenotype of peripheral blood and biopsied liver tissues in hepatitis B patients were examined.
Results:
Among lymphocyte subsets analyzed, CD45RA+CD62L+ subsets were significantly lower in HBV-infected livers than in healthy controls. Intrahepatic naive lymphocytes was negatively correlated with serum viral load (r =-0.47, p<0.05) and liver injury measured by serum alanine aminotransferase (ALT) (r=-0.36, p<0.05). Serum HBV DNA was also negatively associated with intrahepatic CD8+CD95+ (r=-0.49, p<0.01), circulating CD4+HLA-DR+ (r=-0.43, p<0.05) and circulating CD3+CD(16+56)+ (r =-0.35, p<0.05). CD3+CD8+ subsets were positively correlated with serum ALT and HBV DNA (r=0.56, 0.74, p<0.01), respectively.
Conclusions:
These data suggest a key role for the exhaustion of intrahepatic naive lymphocyte reservoir in the development of a weak antiviral immune response and the inability to control viral replication in chronic hepatitis B patients. While cellular immunity is critical to clear the viral load, over-activated cytotoxic lymphocytes may also be involved in hepatic injury.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024